Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07402330 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pharmacokinetic Study of DA-020

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Feb 16, 2026 to Apr 16, 2026
    • Study sites: 1 to 2
    v3
  2. Primary endpoint revisedv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pharmacokinetic Study of DA-020
Trial Details
NCT Number NCT07402330
Lead Sponsor Applied Biology, Inc.
Collaborators: Daniel Alain, Inc., Follea International Limited
Conditions
(from sponsor)		 Chemotherapy Induced Alopecia, Chemotherapy Side Effects
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov